How Can Low-Dose Ketamine, a 'Lifesaving' Drug for Major Depression, Alleviate Symptoms Within Hours? UB Research Reveals How
November 14, 2024
November 14, 2024
BUFFALO, New York, Nov. 14 (TNSres) -- The University at Buffalo (State University of New York) issued the following news release:
University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms of major depression in as little as a few hours with effects lasting for several days.
Published in September in Molecular Psychiatry, the UB di . . .
University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms of major depression in as little as a few hours with effects lasting for several days.
Published in September in Molecular Psychiatry, the UB di . . .